KCNK1

Chr 1

potassium two pore domain channel subfamily K member 1

Also known as: DPK, HOHO, K2P1, K2p1.1, KCNO1, TWIK-1, TWIK1

The protein encoded by this gene forms potassium channels that regulate resting membrane potential and neuronal excitability in brain astrocytes and other tissues, functioning primarily as heterodimers with other potassium channel subunits. Pathogenic variants in KCNK1 cause autosomal dominant epilepsy with febrile seizures plus (EFSP) and focal epilepsy, typically with childhood onset. The gene shows tolerance to loss-of-function variants (pLI 0.03, LOEUF 0.91), suggesting the pathogenic mechanism may not involve simple protein loss.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.91
Clinical SummaryKCNK1
Population Constraint (gnomAD)
Low constraint (pLI 0.03) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.91LOEUF
pLI 0.031
Z-score 1.78
OE 0.40 (0.190.91)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.72Z-score
OE missense 0.85 (0.750.97)
164 obs / 192.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.40 (0.190.91)
00.351.4
Missense OE0.85 (0.750.97)
00.61.4
Synonymous OE1.03
01.21.6
LoF obs/exp: 4 / 10.1Missense obs/exp: 164 / 192.2Syn Z: -0.22
DN
0.81top 10%
GOF
0.92top 5%
LOF
0.1895th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

KCNK1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →